Abstract: Background: Third generation cephalosporins are still most commonly used antibiotics empirically in our setup leading to emergence of resistance in this group. In this environment of increasing resistance, empirical use of this group of antibiotics would be a futile effort. Therefore, this study was conducted to evaluate the in vitro efficacy of fourth generation cephalosporin cefepime against multi-drug resistant isolates of Pseudomonas aeruginosa from various clinical specimens in our setup
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
Background:Infections due to antimicrobial resistant bacteria pose serious problem in the care of th...
To assess the effect of ceftazidime resistance on the activity of other antimicrobial agents, 3030 c...
Cefepime is a potent, broad-spectrum, fourth-generation cephalosporin with enhanced activity against...
The in vitro activity of cefepime was compared to that of a range of other broad-spectrum agents, us...
The in vitro activity of cefepime was compared to that of a range of other broad-spectrum agents, us...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
The comparative in vitro activity and synergy of cefepime were evaluated with clinical isolates of P...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
ObjectiveTo investigate whether stepwise selection of resistance mutations may mirror the continued ...
Background: Recent increase in resistance among gram-negative bacteria, particularly in referral cen...
Abstract: Serious bacterial infections with their high bioburden are often difficult to treat. Emerg...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
Pseudomonas aeruginosa is a leading human pathogen that causes serious infections at various tissues...
The in vitro activity of cefepime was compared with those of ceftazidime, cefotaxime, and cefpfrome ...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
Background:Infections due to antimicrobial resistant bacteria pose serious problem in the care of th...
To assess the effect of ceftazidime resistance on the activity of other antimicrobial agents, 3030 c...
Cefepime is a potent, broad-spectrum, fourth-generation cephalosporin with enhanced activity against...
The in vitro activity of cefepime was compared to that of a range of other broad-spectrum agents, us...
The in vitro activity of cefepime was compared to that of a range of other broad-spectrum agents, us...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
The comparative in vitro activity and synergy of cefepime were evaluated with clinical isolates of P...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
ObjectiveTo investigate whether stepwise selection of resistance mutations may mirror the continued ...
Background: Recent increase in resistance among gram-negative bacteria, particularly in referral cen...
Abstract: Serious bacterial infections with their high bioburden are often difficult to treat. Emerg...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
Pseudomonas aeruginosa is a leading human pathogen that causes serious infections at various tissues...
The in vitro activity of cefepime was compared with those of ceftazidime, cefotaxime, and cefpfrome ...
The in vitro activity of cefepime was compared to that of ceftazidime, ceftriaxone, and cefotaxime i...
Background:Infections due to antimicrobial resistant bacteria pose serious problem in the care of th...
To assess the effect of ceftazidime resistance on the activity of other antimicrobial agents, 3030 c...